Literature DB >> 22582355

Your brain on drugs: imaging of drug-related changes in the central nervous system.

Benita Tamrazi1, Jeevak Almast.   

Abstract

Drug abuse is a substantial problem in society today and is associated with significant morbidity and mortality. Various drugs are associated with serious complications affecting the brain, and it is critical to recognize the imaging findings of these complications to provide prompt medical management. The central nervous system (CNS) is a target organ for drugs of abuse as well as specific prescribed medications. Drugs of abuse affecting the CNS include cocaine, heroin, alcohol, amphetamines, toluene, and cannabis. Prescribed medications or medical therapies that can affect the CNS include immunosuppressants, antiepileptics, nitrous oxide, and total parenteral nutrition. The CNS complications of these drugs include neurovascular complications, encephalopathy, atrophy, infection, changes in the corpus callosum, and other miscellaneous changes. Imaging abnormalities indicative of these complications can be appreciated at both magnetic resonance (MR) imaging and computed tomography (CT). It is critical for radiologists to recognize complications related to drugs of abuse as well as iatrogenic effects of various medications. Therefore, diagnostic imaging modalities such as MR imaging and CT can play a pivotal role in the recognition and timely management of drug-related complications in the CNS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22582355     DOI: 10.1148/rg.323115115

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  15 in total

1.  Cocaine abuse: Longitudinal MR imaging of lasting diffused leukoencephalopathy.

Authors:  Shuo Li; Roni Manyevitch; Kaltrina Sedaliu; Ahmed Abdelbaki; Nishant Gupta; Anil Kumar; Yogesh Kumar; Mark Rosovsky
Journal:  Neuroradiol J       Date:  2018-02-05

2.  Acute brain injury following illicit drug abuse in adolescent and young adult patients: spectrum of neuroimaging findings.

Authors:  Shai Shrot; Andrea Poretti; Elizabeth W Tucker; Bruno P Soares; Thierry Agm Huisman
Journal:  Neuroradiol J       Date:  2017-01-01

Review 3.  Is management of hyperglycaemia in acute phase stroke still a dilemma?

Authors:  C Savopoulos; G Kaiafa; I Kanellos; A Fountouki; D Theofanidis; A I Hatzitolios
Journal:  J Endocrinol Invest       Date:  2016-11-21       Impact factor: 4.256

Review 4.  Imaging spectrum of immunomodulating, chemotherapeutic and radiation therapy-related intracranial effects.

Authors:  Christie M Lincoln; Peter Fata; Susan Sotardi; Michael Pohlen; Tomas Uribe; Jacqueline A Bello
Journal:  Br J Radiol       Date:  2017-11-03       Impact factor: 3.039

5.  Diffuse subcortical white matter injury and bilateral basal ganglia neuronal loss after acute opioid overdose.

Authors:  Andreea I Dinicu; Amit Chaudhari; Simon Kayyal
Journal:  Neuroradiol J       Date:  2020-06

6.  Natural history of pediatric morphine leukoencephalopathy on CT and MRI.

Authors:  Ian Y M Chan; Raza Syed; Michael T Jurkiewicz
Journal:  Emerg Radiol       Date:  2022-08-10

Review 7.  Psychostimulants and cognition: a continuum of behavioral and cognitive activation.

Authors:  Suzanne Wood; Jennifer R Sage; Tristan Shuman; Stephan G Anagnostaras
Journal:  Pharmacol Rev       Date:  2013-12-16       Impact factor: 25.468

Review 8.  Volatile substance misuse: an updated review of toxicity and treatment.

Authors:  Jonathan B Ford; Mark E Sutter; Kelly P Owen; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

9.  Severe, Fatal Methotrexate-related Neurotoxicity in 2 Adolescent Patients With ALL.

Authors:  Sarah Dabagh; Henry David; Sarah Young; Andrew Doan; Deepa Bhojwani
Journal:  J Pediatr Hematol Oncol       Date:  2020-11       Impact factor: 1.170

Review 10.  Neurotoxic Effects of Childhood Cancer Therapy and Its Potential Neurocognitive Impact.

Authors:  Nicholas S Phillips; Elizabeth S Duke; Hannah-Lise T Schofield; Nicole J Ullrich
Journal:  J Clin Oncol       Date:  2021-04-22       Impact factor: 50.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.